Genetic research
Immunogenic Cell Death Biomarkers Predict Prognosis in Lung Adenocarcinoma
Researchers at the Civil Aviation General Hospital in Beijing, China, have identified biomarkers associated with immunogenic cell death (ICD) that can predict prognosis in lung adenocarcinoma (LUAD) patients. The study found that two ICD-associated molecular subgroups had significantly different survival rates, with cluster 1 associated with a favorable prognosis and